Sally Beauty Reports Q1 Results, Raises Low End of FY26 EPS Guidance Amid Strong Cash Flow
summarizeSummary
Sally Beauty Holdings reported first-quarter fiscal 2026 results, with adjusted diluted EPS up 12% and strong cash flow, leading the company to raise the low end of its full-year adjusted EPS guidance.
check_boxKey Events
-
Q1 Financial Performance
Consolidated net sales increased 0.6% to $943 million, with comparable sales flat. Adjusted diluted EPS grew 12% to $0.48, while GAAP diluted EPS decreased 22% to $0.45.
-
Strong Cash Flow & Capital Allocation
The company generated $93 million in cash flow from operations, utilizing it to repay $20 million in term loan debt and repurchase $21 million in shares.
-
Raised Fiscal 2026 EPS Guidance
Sally Beauty raised the low end of its full-year adjusted diluted EPS guidance from $2.00-$2.10 to $2.02-$2.10, maintaining other full-year guidance.
-
Gross Margin Expansion
GAAP gross margin expanded by 40 basis points to 51.2%, and adjusted gross margin expanded by 50 basis points to 51.3%.
auto_awesomeAnalysis
Sally Beauty Holdings reported mixed first-quarter fiscal 2026 results, with modest sales growth and flat comparable sales. While GAAP diluted EPS declined, adjusted diluted EPS showed a healthy 12% increase, reflecting operational improvements when excluding non-recurring items. The company demonstrated strong financial health by generating $93 million in cash flow from operations, which was strategically deployed to reduce debt and repurchase shares. The decision to raise the low end of its full-year adjusted diluted EPS guidance signals management's confidence in future performance, despite the overall full-year guidance remaining largely unchanged. Investors should focus on the adjusted metrics and cash flow generation as key indicators of the company's underlying operational strength and capital allocation strategy.
At the time of this filing, SBH was trading at $16.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $7.54 to $17.92. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.